LexAurum Advisors, LLC

Position in PGEN — Precigen, Inc.

CIK 1729677 OVERLAND PARK, KS

Position in PGEN

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$3,638,954

+$970,926 QoQ

Shares Held

638,413

-7.4% QoQ

Ownership

0.179%

of shares outstanding

% of Portfolio

1.57%

of 13F equity value

Holder Rank

of 12 holders

Holding Since

Mar 2022

17 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

LexAurum Advisors, LLC holds $3,807,433 across 2 Biotechnology names. PGEN ranks #1 (95.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)	Open
1	PGEN	Precigen, Inc. This page	638,413	$3,638,954
2	AVXL	Anavex Life Sciences Corp.	65,050	$168,479

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,638,954	638,413	-7.4%	Shares	Sole	2026-07-15
2026-03-31	$2,668,028	689,413	+3.5%	Shares	Sole	2026-04-13
2025-09-30	$2,191,265	666,038	-1.0%	Shares	Sole	2025-11-06
2025-06-30	$955,011	672,543	-1.9%	Shares	Sole	2025-07-17
2025-03-31	$1,021,094	685,298	-0.9%	Shares	Sole	2025-04-14
2024-12-31	$774,529	691,544	+151.9%	Shares	Sole	2025-01-21
2024-09-30	$260,764	274,489	+13.8%	Shares	Sole	2024-10-17
2024-06-30	$381,078	241,189	+170.5%	Shares	Sole	2024-07-15
2024-03-31	$129,290	89,166	-8.8%	Shares	Sole	2024-04-10
2023-12-31	$131,006	97,766	+5.5%	Shares	Sole	2024-01-10
2023-09-30	$131,585	92,666	-9.1%	Shares	Sole	2023-10-16
2023-06-30	$117,260	101,966	-1.9%	Shares	Sole	2023-07-25
2023-03-31	$110,203	103,966	-5.5%	Shares	Sole	2023-04-11
2022-12-31	$167,155	109,971	-26.0%	Shares	Sole	2023-01-23
2022-09-30	$315,182	148,671	-2.6%	Shares	Sole	2022-10-17
2022-06-30	$204,579	152,671	+2.6%	Shares	Sole	2022-08-05
2022-03-31	$314,117	148,871	—	Shares	Sole	2022-05-04
No filing history on record for this holder in this stock.